{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:00:35Z","timestamp":1790092835973,"version":"4.0.1"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["R25MH081482"],"award-info":[{"award-number":["R25MH081482"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"U.S. Department of Health & Human Services | NIH | National Institute of Mental Health","doi-asserted-by":"publisher","award":["T32MH018399"],"award-info":[{"award-number":["T32MH018399"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA051295"],"award-info":[{"award-number":["R01DA051295"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol."],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1038\/s41386-026-02489-w","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T14:59:00Z","timestamp":1784645940000},"page":"2132-2140","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evidence for pro-cognitive benefits of cannabinoids in people with bipolar disorder"],"prefix":"10.1038","volume":"51","author":[{"given":"Alannah","family":"Miranda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Breanna M.","family":"Holloway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Peek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holden","family":"Rosberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam L.","family":"Halberstadt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Grelotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Perry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3732-5776","authenticated-orcid":false,"given":"Jared W.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arpi","family":"Minassian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,21]]},"reference":[{"key":"2489_CR1","doi-asserted-by":"publisher","first-page":"680","DOI":"10.4088\/JCP.v64n0610","volume":"64","author":"RM Post","year":"2003","unstructured":"Post RM, Denicoff KD, Leverich GS, Altshuler LL, Frye MA, Suppes TM, et al. Morbidity in 258 bipolar outpatients followed for 1 year with daily prospective ratings on the NIMH life chart method. J Clin Psychiatry. 2003;64:680\u201390.","journal-title":"J Clin Psychiatry"},{"key":"2489_CR2","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.schres.2020.06.033","volume":"223","author":"MY Gotra","year":"2020","unstructured":"Gotra MY, Hill SK, Gershon ES, Tamminga CA, Ivleva EI, Pearlson GD, et al. Distinguishing patterns of impairment on inhibitory control and general cognitive ability among bipolar with and without psychosis, schizophrenia, and schizoaffective disorder. Schizophr Res. 2020;223:148\u201357.","journal-title":"Schizophr Res"},{"key":"2489_CR3","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.biopsych.2016.09.006","volume":"82","author":"D Pagliaccio","year":"2017","unstructured":"Pagliaccio D, Wiggins JL, Adleman NE, Harkins E, Curhan A, Towbin KE, et al. Behavioral and neural sustained attention deficits in bipolar disorder and familial risk of bipolar disorder. Biol Psychiatry. 2017;82:669\u201378.","journal-title":"Biol Psychiatry"},{"key":"2489_CR4","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1080\/17523281.2012.659751","volume":"5","author":"SA Gruber","year":"2012","unstructured":"Gruber SA, Sagar KA, Dahlgren MK, Olson DP, Centorrino F, Lukas SE. Marijuana impacts mood in bipolar disorder: a pilot study. Ment Health Subst Use. 2012;5:228\u201339.","journal-title":"Ment Health Subst Use"},{"key":"2489_CR5","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1111\/j.1600-0447.2011.01687.x","volume":"124","author":"CH Ashton","year":"2011","unstructured":"Ashton CH, Moore PB. Endocannabinoid system dysfunction in mood and related disorders. Acta Psychiatr Scand. 2011;124:250\u201361.","journal-title":"Acta Psychiatr Scand"},{"key":"2489_CR6","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1080\/02791072.1998.10399687","volume":"30","author":"L Grinspoon","year":"1998","unstructured":"Grinspoon L, Bakalar JB. The use of cannabis as a mood stabilizer in bipolar disorder: anecdotal evidence and the need for clinical research. J Psychoact Drugs. 1998;30:171\u20137.","journal-title":"J Psychoact Drugs"},{"key":"2489_CR7","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.psychres.2010.07.007","volume":"185","author":"A Agrawal","year":"2011","unstructured":"Agrawal A, Nurnberger JI, Lynskey MT. Cannabis involvement in individuals with bipolar disorder. Psychiatry Res. 2011;185:459.","journal-title":"Psychiatry Res"},{"key":"2489_CR8","doi-asserted-by":"publisher","unstructured":"Dellazizzo L, Potvin S, Gigu\u00e8re S, Dumais A. Evidence on the acute and residual neurocognitive effects of cannabis use in adolescents and adults: a systematic meta-review of meta-analyses. 2021. https:\/\/doi.org\/10.1111\/add.15764.","DOI":"10.1111\/add.15764"},{"key":"2489_CR9","doi-asserted-by":"crossref","unstructured":"Walter TJ, Pocuca N, Young JW, Geyer MA, Minassian A, Perry W. The relationship between cannabis use and cognition in people with bipolar disorder: a systematic scoping review. Psychiatry Res. 2021;297:113695.","DOI":"10.1016\/j.psychres.2020.113695"},{"key":"2489_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-025-03718-4","volume":"15","author":"A Miranda","year":"2025","unstructured":"Miranda A, Roberts BZ, Holloway BM, Peek E, Rosberg H, Ayoub SM, et al. Chronic cannabis use in people with bipolar disorder is associated with comparable decision-making and functional outcome to healthy participants. Transl Psychiatry. 2025;15:506.","journal-title":"Transl Psychiatry"},{"key":"2489_CR11","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.psychres.2012.05.025","volume":"200","author":"RJ Braga","year":"2012","unstructured":"Braga RJ, Burdick KE, DeRosse P, Malhotra AK. Cognitive and clinical outcomes associated with cannabis use in patients with bipolar I disorder. Psychiatry Res. 2012;200:242\u20135.","journal-title":"Psychiatry Res"},{"key":"2489_CR12","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1017\/S0033291709991620","volume":"40","author":"PA Ringen","year":"2010","unstructured":"Ringen PA, Vaskinn A, Sundet K, Engh JA, J\u00f3nsd\u00f3ttir H, Simonsen C, et al. Opposite relationships between cannabis use and neurocognitive functioning in bipolar disorder and schizophrenia. Psychol Med. 2010;40:1337\u201347.","journal-title":"Psychol Med"},{"key":"2489_CR13","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1111\/bdi.12786","volume":"22","author":"JW Young","year":"2020","unstructured":"Young JW, Geyer MA, Halberstadt AL, van Enkhuizen J, Minassian A, Khan A, et al. Convergent neural substrates of inattention in bipolar disorder patients and dopamine transporter-deficient mice using the 5-choice CPT. Bipolar Disord. 2020;22:46\u201358.","journal-title":"Bipolar Disord"},{"key":"2489_CR14","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.neuropharm.2018.05.034","volume":"138","author":"DA MacQueen","year":"2018","unstructured":"MacQueen DA, Minassian A, Kenton JA, Geyer MA, Perry W, Brigman JL, et al. Amphetamine improves mouse and human attention in the 5-choice continuous performance test. Neuropharmacology. 2018;138:87\u201396.","journal-title":"Neuropharmacology"},{"key":"2489_CR15","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1007\/s00213-020-05511-1","volume":"237","author":"JW Young","year":"2020","unstructured":"Young JW, Roberts BZ, Breier M, Swerdlow NR. Amphetamine improves rat 5-choice continuous performance test (5C-CPT) irrespective of concurrent low-dose haloperidol treatment. Psychopharmacology. 2020;237:1959\u201372.","journal-title":"Psychopharmacology"},{"key":"2489_CR16","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1037\/bul0000045","volume":"142","author":"WJ Matthews","year":"2016","unstructured":"Matthews WJ, Meck WH. Temporal cognition: connecting subjective time to perception, attention, and memory. Psychol Bull. 2016;142:865\u2013907.","journal-title":"Psychol Bull"},{"key":"2489_CR17","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.actpsy.2013.11.003","volume":"149","author":"RA Block","year":"2014","unstructured":"Block RA, Gruber RP. Time perception, attention, and memory: a selective review. Acta Psychol. 2014;149:129\u201333.","journal-title":"Acta Psychol"},{"key":"2489_CR18","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.actpsy.2016.12.004","volume":"173","author":"SW Brown","year":"2017","unstructured":"Brown SW, Perreault ST. Relation between temporal perception and inhibitory control in the Go\/No-Go task. Acta Psychol. 2017;173:87\u201393.","journal-title":"Acta Psychol"},{"key":"2489_CR19","doi-asserted-by":"publisher","first-page":"567","DOI":"10.2174\/18715273113129990080","volume":"12","author":"S Teixeira","year":"2013","unstructured":"Teixeira S, Machado S, Paes F, Velasques B, Silva J, Sanfim A, et al. Time perception distortion in neuropsychiatric and neurological disorders. CNS Neurol Disord Drug Targets. 2013;12:567\u201382.","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"2489_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-16198-z","volume":"12","author":"RS Ogden","year":"2022","unstructured":"Ogden RS, Dobbins C, Slade K, McIntyre J, Fairclough S. The psychophysiological mechanisms of real-world time experience. Sci Rep. 2022;12:12890. 2022 12:1.","journal-title":"Sci Rep"},{"key":"2489_CR21","doi-asserted-by":"publisher","unstructured":"White E, Dalley JW. Brain mechanisms of temporal processing in impulsivity: Relevance to attention-deficit hyperactivity disorder. Brain Neurosci Adv. 2024;8. https:\/\/doi.org\/10.1177\/23982128241272234.","DOI":"10.1177\/23982128241272234"},{"key":"2489_CR22","doi-asserted-by":"crossref","unstructured":"Bolbecker AR, Westfall DR, Howell JM, Lackner RJ, Carroll CA, O\u2019Donnell BF, et al. Increased timing variability in schizophrenia and bipolar disorder. PLoS One. 2014;9:e97964.","DOI":"10.1371\/journal.pone.0097964"},{"key":"2489_CR23","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jad.2022.07.063","volume":"315","author":"V Ciullo","year":"2022","unstructured":"Ciullo V, Piras F, Banaj N, Vecchio D, Piras F, Sani G, et al. Internal clock variability, mood swings and working memory in bipolar disorder. J Affect Disord. 2022;315:48\u201356.","journal-title":"J Affect Disord"},{"key":"2489_CR24","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/j.1399-5618.2011.00895.x","volume":"13","author":"AR Bolbecker","year":"2011","unstructured":"Bolbecker AR, Hong SL, Kent JS, Forsyth JK, Klaunig MJ, Lazar EK, et al. Paced finger-tapping abnormalities in bipolar disorder indicate timing dysfunction. Bipolar Disord. 2011;13:99\u2013110.","journal-title":"Bipolar Disord"},{"key":"2489_CR25","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.pnpbp.2014.07.009","volume":"56","author":"V Ryu","year":"2015","unstructured":"Ryu V, Kook S, Lee SJ, Ha K, Cho HS. Effects of emotional stimuli on time perception in manic and euthymic patients with bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2015;56:39\u201345.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"2489_CR26","doi-asserted-by":"crossref","unstructured":"Liu P, Guo H, Ma R, Liu S, Wang X, Zhao K, et al. Identifying the difference in time perception between major depressive disorder and bipolar depression through a temporal bisection task. PLoS One. 2022;17:e0277076.","DOI":"10.1371\/journal.pone.0277076"},{"key":"2489_CR27","doi-asserted-by":"publisher","first-page":"4915","DOI":"10.2174\/138161212802884852","volume":"18","author":"Z Atakan","year":"2012","unstructured":"Atakan Z, Morrison P, G Bossong M, Martin-Santos R, A Crippa J. The effect of cannabis on perception of time: a critical review. Curr Pharm Des. 2012;18:4915\u201322.","journal-title":"Curr Pharm Des"},{"key":"2489_CR28","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s00213-012-2915-6","volume":"226","author":"RA Sewell","year":"2013","unstructured":"Sewell RA, Schnakenberg A, Elander J, Radhakrishnan R, Williams A, Skosnik PD, et al. Acute effects of THC on time perception in frequent and infrequent cannabis users. Psychopharmacology. 2013;226:401\u201313.","journal-title":"Psychopharmacology"},{"key":"2489_CR29","doi-asserted-by":"publisher","first-page":"3513","DOI":"10.1007\/s00213-016-4389-4","volume":"233","author":"ZA Cope","year":"2016","unstructured":"Cope ZA, Halberstadt AL, van Enkhuizen J, Flynn AD, Breier M, Swerdlow NR, et al. Premature responses in the five-choice serial reaction time task reflect rodents\u2019 temporal strategies: evidence from no-light and pharmacological challenges. Psychopharmacology. 2016;233:3513\u201325.","journal-title":"Psychopharmacology"},{"key":"2489_CR30","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1002\/mpr.1379","volume":"22","author":"M Lukasiewicz","year":"2013","unstructured":"Lukasiewicz M, Gerard S, Besnard A, Falissard B, Perrin E, Sapin H, et al. Young Mania Rating Scale: how to interpret the numbers? Determination of a severity threshold and of the minimal clinically significant difference in the EMBLEM cohort. Int J Methods Psychiatr Res. 2013;22:46.","journal-title":"Int J Methods Psychiatr Res"},{"key":"2489_CR31","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.jad.2013.04.028","volume":"150","author":"M Zimmerman","year":"2013","unstructured":"Zimmerman M, Martinez JH, Young D, Chelminski I, Dalrymple K. Severity classification on the Hamilton depression rating scale. J Affect Disord. 2013;150:384\u20138.","journal-title":"J Affect Disord"},{"key":"2489_CR32","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1038\/npp.2015.108","volume":"40","author":"M Haney","year":"2015","unstructured":"Haney M, Ramesh D, Glass A, Pavlicova M, Bedi G, Cooper ZD. Naltrexone maintenance decreases cannabis self-administration and subjective effects in daily cannabis smokers. Neuropsychopharmacology. 2015;40:2489\u201398.","journal-title":"Neuropsychopharmacology"},{"key":"2489_CR33","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1038\/npp.2013.324","volume":"39","author":"EA Henry","year":"2014","unstructured":"Henry EA, Kaye JT, Bryan AD, Hutchison KE, Ito TA. Cannabis cue reactivity and craving among never, infrequent and heavy cannabis users. Neuropsychopharmacology. 2014;39:1214\u201321.","journal-title":"Neuropsychopharmacology"},{"key":"2489_CR34","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1037\/abn0000224","volume":"126","author":"S Papini","year":"2017","unstructured":"Papini S, Ruglass LM, Lopez-Castro T, Powers MB, Smits JAJ, Hien DA. Chronic cannabis use is associated with impaired fear extinction in humans. J Abnorm Psychol. 2017;126:117\u201324.","journal-title":"J Abnorm Psychol"},{"key":"2489_CR35","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1177\/0269881108092393","volume":"23","author":"JG Ramaekers","year":"2009","unstructured":"Ramaekers JG, Kauert G, Theunissen EL, Toennes SW, Moeller MR. Neurocognitive performance during acute THC intoxication in heavy and occasional cannabis users. J Psychopharmacol. 2009;23:266\u201377.","journal-title":"J Psychopharmacol"},{"key":"2489_CR36","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1212\/01.WNL.0000031422.66442.49","volume":"59","author":"KI Bolla","year":"2002","unstructured":"Bolla KI, Brown K, Eldreth D, Tate K, Cadet JL. Dose-related neurocognitive effects of marijuana use. Neurology. 2002;59:1337\u201343.","journal-title":"Neurology"},{"key":"2489_CR37","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1080\/09540121.2015.1124983","volume":"28","author":"AD Thames","year":"2016","unstructured":"Thames AD, Mahmood Z, Burggren AC, Karimian A, Kuhn TP. Combined effects of HIV and marijuana use on neurocognitive functioning and immune status. AIDS Care. 2016;28:628\u201332.","journal-title":"AIDS Care"},{"key":"2489_CR38","doi-asserted-by":"crossref","unstructured":"Young JW, Light GA, Marston HM, Sharp R, Geyer MA. The 5-choice continuous performance test: evidence for a translational test of vigilance for mice. PLoS One. 2009;4:e4227.","DOI":"10.1371\/journal.pone.0004227"},{"key":"2489_CR39","doi-asserted-by":"publisher","first-page":"9.56.1","DOI":"10.1002\/cpns.20","volume":"78","author":"ZA Cope","year":"2017","unstructured":"Cope ZA, Young JW. The five-choice continuous performance task (5C-CPT): a cross-species relevant paradigm for assessment of vigilance and response inhibition in rodents. Curr Protoc Neurosci. 2017;78:9.56.1.","journal-title":"Curr Protoc Neurosci"},{"key":"2489_CR40","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jneumeth.2017.07.011","volume":"292","author":"SG Bhakta","year":"2017","unstructured":"Bhakta SG, Young JW. The 5 choice continuous performance test (5C-CPT): a novel tool to assess cognitive control across species. J Neurosci Methods. 2017;292:53\u201360.","journal-title":"J Neurosci Methods"},{"key":"2489_CR41","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1111\/jnc.16117","volume":"168","author":"C Salmon","year":"2024","unstructured":"Salmon C, Li S, Burrows EL, Johnson KA. Translational validity of neuropsychological tasks of sustained attention between rodents and humans: a systematic review of three rodent tasks. J Neurochem. 2024;168:2170\u201389.","journal-title":"J Neurochem"},{"key":"2489_CR42","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/0023-9690(73)90023-4","volume":"4","author":"PW Frey","year":"1973","unstructured":"Frey PW, Colliver JA. Sensitivity and responsivity measures for discrimination learning. Learn Motiv. 1973;4:327\u201342.","journal-title":"Learn Motiv"},{"key":"2489_CR43","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/BF00179942","volume":"93","author":"A Sahgal","year":"1987","unstructured":"Sahgal A. Contrasting effects of vasopressin, desglycinamide-vasopressin and amphetamine on a delayed matching to position task in rats. Psychopharmacology. 1987;93:243\u20139.","journal-title":"Psychopharmacology"},{"key":"2489_CR44","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.neuropharm.2016.03.038","volume":"107","author":"AL Halberstadt","year":"2016","unstructured":"Halberstadt AL, Sindhunata IS, Scheffers K, Flynn AD, Sharp RF, Geyer MA, et al. EFFECT OF 5-Ht2a and 5-Ht2c receptors on temporal discrimination by mice. Neuropharmacology. 2016;107:364.","journal-title":"Neuropharmacology"},{"key":"2489_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.596601","volume":"12","author":"J Bourque","year":"2021","unstructured":"Bourque J, Potvin S. Cannabis and cognitive functioning: from acute to residual effects, from randomized controlled trials to prospective designs. Front Psychiatry. 2021;12:596601.","journal-title":"Front Psychiatry"},{"key":"2489_CR46","doi-asserted-by":"crossref","unstructured":"Ayoub SM, Holloway BM, Miranda AH, Roberts BZ, Young JW, Minassian A, et al. The impact of cannabis use on cognition in people with hiv: evidence of function-dependent effects and mechanisms from clinical and preclinical studies. Curr HIV\/AIDS Rep. 2024;21:87\u2013115.","DOI":"10.1007\/s11904-024-00698-w"},{"key":"2489_CR47","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1093\/arclin\/acaa105","volume":"36","author":"N Pocuca","year":"2021","unstructured":"Pocuca N, Walter TJ, Minassian A, Young JW, Geyer MA, Perry W. The effects of cannabis use on cognitive function in healthy aging: a systematic scoping review. Arch Clin Neuropsychol. 2021;36:673\u201385.","journal-title":"Arch Clin Neuropsychol"},{"key":"2489_CR48","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1038\/s41386-022-01281-w","volume":"47","author":"CH Murray","year":"2022","unstructured":"Murray CH, Huang Z, Lee R, de Wit H. Adolescents are more sensitive than adults to acute behavioral and cognitive effects of THC. Neuropsychopharmacology. 2022;47:1331\u20138.","journal-title":"Neuropsychopharmacology"},{"key":"2489_CR49","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1177\/0269881119862533","volume":"33","author":"E Pabon","year":"2019","unstructured":"Pabon E, de Wit H. Developing a phone-based measure of impairment after acute oral \u03949-tetrahydrocannabinol. J Psychopharmacol. 2019;33:1160.","journal-title":"J Psychopharmacol"},{"key":"2489_CR50","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1038\/sj.npp.1300176","volume":"28","author":"J McDonald","year":"2003","unstructured":"McDonald J, Schleifer L, Richards JB, De Wit H. Effects of THC on behavioral measures of impulsivity in humans. Neuropsychopharmacology. 2003;28:1356\u201365.","journal-title":"Neuropsychopharmacology"},{"key":"2489_CR51","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1055\/s-0030-1255030","volume":"43","author":"JM Stone","year":"2010","unstructured":"Stone JM, Morrison PD, Nottage J, Bhattacharyya S, Feilding A, McGuire PK. Delta-9-tetrahydrocannabinol disruption of time perception and of self-timed actions. Pharmacopsychiatry. 2010;43:236\u20137.","journal-title":"Pharmacopsychiatry"},{"key":"2489_CR52","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1097\/00001756-200306110-00009","volume":"14","author":"DS O\u2019Leary","year":"2003","unstructured":"O\u2019Leary DS, Block RI, Turner BM, Koeppel J, Magnotta VA, Ponto LB, et al. Marijuana alters the human cerebellar clock. Neuroreport. 2003;14:1145\u201351.","journal-title":"Neuroreport"},{"key":"2489_CR53","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/s41386-025-02262-5","volume":"51","author":"MG Mart\u00ednez-Montalvo","year":"2025","unstructured":"Mart\u00ednez-Montalvo MG, Ortega-Romero DI, B\u00e1ez-Cordero AS, S\u00e1nchez-Lobato O, P\u00e9rez-D\u00edaz CI, Rueda-Orozco PE. Differential cannabinergic effects on temporal perception and production. Neuropsychopharmacology. 2025;51:672.","journal-title":"Neuropsychopharmacology"},{"key":"2489_CR54","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1159\/000106476","volume":"55","author":"JD Amsterdam","year":"2007","unstructured":"Amsterdam JD, Newberg AB. A preliminary study of dopamine transporter binding in bipolar and unipolar depressed patients and healthy controls. Neuropsychobiology. 2007;55:167\u201370.","journal-title":"Neuropsychobiology"},{"key":"2489_CR55","doi-asserted-by":"publisher","first-page":"3455","DOI":"10.1007\/s00213-015-4000-4","volume":"232","author":"J van Enkhuizen","year":"2015","unstructured":"van Enkhuizen J, Milienne-Petiot M, Geyer MA, Young JW. Modeling bipolar disorder in mice by increasing acetylcholine or dopamine: chronic lithium treats most, but not all features. Psychopharmacology. 2015;232:3455\u201367.","journal-title":"Psychopharmacology"},{"key":"2489_CR56","doi-asserted-by":"publisher","first-page":"3112","DOI":"10.1038\/npp.2014.170","volume":"39","author":"J Van Enkhuizen","year":"2014","unstructured":"Van Enkhuizen J, Henry BL, Minassian A, Perry W, Milienne-Petiot M, Higa KK, et al. Reduced dopamine transporter functioning induces high-reward risk-preference consistent with bipolar disorder. Neuropsychopharmacology. 2014;39:3112\u201322.","journal-title":"Neuropsychopharmacology"},{"key":"2489_CR57","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/npp.2015.192","volume":"41","author":"M Kohno","year":"2016","unstructured":"Kohno M, Nurmi EL, Laughlin CP, Morales AM, Gail EH, Hellemann GS, et al. Functional genetic variation in dopamine signaling moderates prefrontal cortical activity during risky decision making. Neuropsychopharmacology. 2016;41:695\u2013703.","journal-title":"Neuropsychopharmacology"},{"key":"2489_CR58","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1001\/jamapsychiatry.2022.3541","volume":"79","author":"LN Yatham","year":"2022","unstructured":"Yatham LN, Liddle PF, Gonzalez M, Saraf G, Vafai N, Lam RW, et al. A positron emission tomography study of dopamine transporter density in patients with bipolar disorder with current mania and those with recently remitted mania. JAMA Psychiatry. 2022;79:1217\u201324.","journal-title":"JAMA Psychiatry"},{"key":"2489_CR59","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/j.1399-5618.2011.00936.x","volume":"13","author":"A Anand","year":"2011","unstructured":"Anand A, Barkay G, Dzemidzic M, Albrecht D, Karne H, Zheng QH, et al. Striatal dopamine transporter availability in unmedicated bipolar disorder. Bipolar Disord. 2011;13:406\u201313.","journal-title":"Bipolar Disord"},{"key":"2489_CR60","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/1096-8628(2001)9999:9999<::AID-AJMG1161>3.0.CO;2-8","volume":"105","author":"TA Greenwood","year":"2001","unstructured":"Greenwood TA, Alexander M, Keck PE, Mcelroy S, Sadovnick AD, Remick RA, et al. Evidence for linkage disequilibrium between the dopamine transporter and bipolar disorder. Am J Med Genet. 2001;105:145\u201351.","journal-title":"Am J Med Genet"},{"key":"2489_CR61","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/sj.mp.4001764","volume":"11","author":"TA Greenwood","year":"2006","unstructured":"Greenwood TA, Schork NJ, Eskin E, Kelsoe JR. Identification of additional variants within the human dopamine transporter gene provides further evidence for an association with bipolar disorder in two independent samples. Mol Psychiatry. 2006;11:125\u201333.","journal-title":"Mol Psychiatry"},{"key":"2489_CR62","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.neubiorev.2007.05.009","volume":"31","author":"JW Young","year":"2007","unstructured":"Young JW, Minassian A, Paulus MP, Geyer MA, Perry W. A reverse-translational approach to bipolar disorder: rodent and human studies in the Behavioral Pattern Monitor. Neurosci Biobehav Rev. 2007;31:882\u201396.","journal-title":"Neurosci Biobehav Rev"},{"key":"2489_CR63","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1001\/archgenpsychiatry.2009.58","volume":"66","author":"W Perry","year":"2009","unstructured":"Perry W, Minassian A, Paulus MP, Young JW, Kincaid MJ, Ferguson EJ, et al. A reverse-translational study of dysfunctional exploration in psychiatric disorders: from mice to men. Arch Gen Psychiatry. 2009;66:1072\u201380.","journal-title":"Arch Gen Psychiatry"},{"key":"2489_CR64","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1007\/s00213-017-4543-7","volume":"234","author":"M Milienne-Petiot","year":"2017","unstructured":"Milienne-Petiot M, Geyer MA, Arnt J, Young JW. Brexpiprazole reduces hyperactivity, impulsivity, and risk-preference behavior in mice with dopamine transporter knockdown-a model of mania. Psychopharmacology. 2017;234:1017\u201328.","journal-title":"Psychopharmacology"},{"key":"2489_CR65","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1177\/0269881111400646","volume":"25","author":"JW Young","year":"2011","unstructured":"Young JW, Van Enkhuizen J, Winstanley CA, Geyer MA. Increased risk-taking behavior in dopamine transporter knockdown mice: further support for a mouse model of mania. J Psychopharmacol. 2011;25:934\u201343.","journal-title":"J Psychopharmacol"},{"key":"2489_CR66","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.neubiorev.2021.02.030","volume":"125","author":"BJ Fung","year":"2021","unstructured":"Fung BJ, Sutlief E, Hussain Shuler MG. Dopamine and the interdependency of time perception and reward. Neurosci Biobehav Rev. 2021;125:380\u201391.","journal-title":"Neurosci Biobehav Rev"},{"key":"2489_CR67","doi-asserted-by":"crossref","unstructured":"Parker KL, Lamichhane D, Caetano MS, Narayanan NS. Executive dysfunction in Parkinson\u2019s disease and timing deficits. Front Integr Neurosci. 2013;7:75.","DOI":"10.3389\/fnint.2013.00075"},{"key":"2489_CR68","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.bandc.2007.01.005","volume":"64","author":"JG Smith","year":"2007","unstructured":"Smith JG, Harper DN, Gittings D, Abernethy D. The effect of Parkinson\u2019s disease on time estimation as a function of stimulus duration range and modality. Brain Cogn. 2007;64:130\u201343.","journal-title":"Brain Cogn"},{"key":"2489_CR69","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1037\/0735-7044.116.2.291","volume":"116","author":"CV Buhusi","year":"2002","unstructured":"Buhusi CV, Meck WH. Differential effects of methamphetamine and haloperidol on the control of an internal clock. Behav Neurosci. 2002;116:291\u20137.","journal-title":"Behav Neurosci"},{"key":"2489_CR70","doi-asserted-by":"publisher","first-page":"16704","DOI":"10.1523\/JNEUROSCI.1258-12.2012","volume":"32","author":"JT Coull","year":"2012","unstructured":"Coull JT, Hwang HJ, Leyton M, Dagher A. Dopamine precursor depletion impairs timing in healthy volunteers by attenuating activity in putamen and supplementary motor area. J Neurosci. 2012;32:16704\u201315.","journal-title":"J Neurosci"},{"key":"2489_CR71","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.bbr.2016.05.045","volume":"311","author":"BB Tournier","year":"2016","unstructured":"Tournier BB, Tsartsalis S, Dimiziani A, Millet P, Ginovart N. Time-dependent effects of repeated THC treatment on dopamine D2\/3 receptor-mediated signalling in midbrain and striatum. Behav Brain Res. 2016;311:322\u20139.","journal-title":"Behav Brain Res"},{"key":"2489_CR72","doi-asserted-by":"crossref","unstructured":"Tournier BB, Dimiziani A, Tsartsalis S, Millet P, Ginovart N. Different effects of chronic THC on the neuroadaptive response of dopamine D2\/3 receptor-mediated signaling in roman high- and roman low-avoidance rats. Synapse. 2018;72:e22023.","DOI":"10.1002\/syn.22023"},{"key":"2489_CR73","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/nature20153","volume":"539","author":"MAP Bloomfield","year":"2016","unstructured":"Bloomfield MAP, Ashok AH, Volkow ND, Howes OD. The effects of \u03949-tetrahydrocannabinol on the dopamine system. Nature. 2016;539:369.","journal-title":"Nature"},{"key":"2489_CR74","doi-asserted-by":"crossref","unstructured":"Volkow ND, Wang GJ, Telang F, Fowler JS, Alexoff D, Logan J, et al. Decreased dopamine brain reactivity in marijuana abusers is associated with negative emotionality and addiction severity. Proc Natl Acad Sci USA. 2014;111:E3149-56.","DOI":"10.1073\/pnas.1411228111"},{"key":"2489_CR75","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/mp.2016.21","volume":"22","author":"E Van De Giessen","year":"2017","unstructured":"Van De Giessen E, Weinstein JJ, Cassidy CM, Haney M, Dong Z, Ghazzaoui R, et al. Deficits in striatal dopamine release in cannabis dependence. Mol Psychiatry. 2017;22:68\u201375.","journal-title":"Mol Psychiatry"},{"key":"2489_CR76","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s13659-020-00263-z","volume":"10","author":"S Chetia","year":"2020","unstructured":"Chetia S, Borah G, Chetia S, Borah G. \u0394 9-tetrahydrocannabinol toxicity and validation of cannabidiol on brain dopamine levels: an assessment on cannabis duplicity. Nat Products Bioprospecting. 2020;10:285\u201396. 2020 10:5.","journal-title":"Nat Products Bioprospecting"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41386-026-02489-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41386-026-02489-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41386-026-02489-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T15:06:14Z","timestamp":1790089574000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41386-026-02489-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,21]]},"references-count":76,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["2489"],"URL":"https:\/\/doi.org\/10.1038\/s41386-026-02489-w","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,21]]},"assertion":[{"value":"26 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}